tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

LivaNova price target lowered to $55 from $56 at Barclays

Barclays lowered the firm’s price target on LivaNova (LIVN) to $55 from $56 and keeps an Equal Weight rating on the shares. The company reported a “robust beat” and its sales guidance was raised, the analyst tells investors in a research note. The firm says LivaNova’s Cardio and Epilepsy are on track for a solid 2025 performance.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1